Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Crossref DOI link: https://doi.org/10.1038/s41422-022-00713-y
Published Online: 2022-09-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hoffmann, Markus http://orcid.org/0000-0003-4603-7696
Jin, Yeonhwa
Pöhlmann, Stefan http://orcid.org/0000-0001-6086-9136
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
First Online: 1 September 2022